CSIR's cancer drug enters clinical trials
Science & Technology
CSIR's cancer drug enters clinical trials
June 08, 2020
1 min
  • A CSIR lab has received approval to conduct clinical trials of a new drug in pancreatic cancer patients.
  • Indian Institue of Integrative Medicine, Jammu is a drug research laboratory that works under the Council of Scientific & Industrial Research.
  • This approval has been given by the New Drugs Division of Central Drugs Standard Control Organization (CDSCO).
  • This drug has been created using the content from the leaves of Indian white cedar.
  • Globally, pancreatic cancer causes more than 2.5 lakh deaths annually.
  • This cancer is considered as one of the untreatable cancer types, because of its very late diagnosis.


JammuCentral Drugs Standard Control OrganisationJammu and KashmirCouncil of Scientific & Industrial ResearchPancreatic cancer
Previous Article
Lieutenant Governor over-rules Delhi Government decision for hospital reservation

Related Posts

NCL Pune develops indigenous nasopharyngeal swabs
June 06, 2020
1 min
© 2021, All Rights Reserved.
Made with in भारत



Legal Stuff

Social Media